 |
autologous ex vivo expanded polyclonal CD4+CD25+CD1271o/-FOXP3+ Regulatory T cells |
|---|---|
| Trade Name | |
| Orphan Indication | Type 1 diabetes mellitus with residual beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-10 00:00:00 |
| Sponsor | Caladrius Biosciences;110 Allen Road, 2nd Floor;Basking Ridge, New Jersey, 07920 |
